Special Containment Procedures: Sec

特殊收容措施：Site-34的安全人员被指示报告任何提及SCP-5030的信息。参与这些转诊的人员应接受参与该项目的工作人员的采访，并接受特定的对策接种或接受C级或G级记忆删除，这取决于他们与初始病媒的接近程度和感染的严重程度。治疗后，应至少观察受试者60天。<br><br>监视机器人ORWELL-4将持续搜索基金会的内部信息网络，以获取有关SCP-5030的提及和引用，一旦将它们自动注册以进行进一步分析，就将其消除。此外，应按照上一段中的描述对待这些参考文献的作者。<br><br>为了预防与SCP-5030相关的影响，Site-34的工作人员应接种模因制剂ES-5030-M（“城市传说”）。据估计，到2019年7月底，将有超过97％的工作人员接种该药剂，这可能导致完全预防与异常有关的影响。

Special Containment Procedures: Security personnel at the Site-34 have been instructed to report any mention of SCP-5030. Those responsible for these referrals should be interviewed by staff members participating in the project, and either inoculated with a specific countermeasure or treated with Class C or G amnestics depending on their level of proximity to the initial vector and severity of the infection. After treatment, subjects should be observed for a minimum of 60 days.<br><br>Surveillance bot ORWELL-4 will search continuously the internal informatics network of the Foundation for mentions of and references about SCP-5030, eliminating them once they've been automatically registered for further analysis. Additionally, authors of these references should be treated as described in the previous paragraph.<br><br>As a preventive measure against the effects associated with SCP-5030, the staff members at Site-34 are to be inoculated with the memetic agent ES-5030-M ("Urban Legend"). It is estimated that by the end of July 2019 over 97% of the staff members will be inoculated with this agent, which could lead to total prevention of the effects associated with the anomaly.

特别遏制程序：已指示34号现场的安保人员报告任何提及SCP-5030的情况。参与该项目的工作人员应与这些转介的负责人面谈，根据他们与最初传播媒介的接近程度和感染的严重程度，要么接种特定对策，要么使用C或G类健忘症药物治疗。治疗后，受试者应至少观察60天。<br>监视机器人ORWELL-4将不断搜索基金会内部信息网络，以供提及和参考SCP-5030，一旦它们被自动注册以供进一步分析，就将其删除。此外，这些参考文献的作者应按前一段所述处理。<br>作为预防SCP-5030相关影响的措施，34号现场的工作人员将接种记忆剂ES-5030-M（“城市传说”）。据估计，到2019年7月底，超过97%的工作人员将接种这种药剂，这可能导致完全预防与异常有关的影响。